Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Madrigal Pharmaceuticals Inc (NQ: MDGL )

280.27 +1.86 (+0.67%)
Streaming Delayed Price Updated: 10:48 AM EDT, Jun 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,487
Open 278.00
Bid (Size) 280.04 (4)
Ask (Size) 281.71 (4)
Prev. Close 278.41
Today's Range 272.39 - 281.01
52wk Range 57.21 - 322.67
Shares Outstanding 17,103,395
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall Street
Recent moves to the upside could be the beginning of a much larger bull run. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga

Performance

YTD
-1.81%
-1.81%
1 Month
-9.41%
-9.41%
3 Month
+0.39%
+0.39%
6 Month
+299.75%
+299.75%
1 Year
+322.15%
+322.15%

More News

Read More
Why Madrigal Pharmaceuticals Stock Is Marching Higher Today
Via The Motley Fool
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
Intercept Crashes As FDA Advisors Deliver The Likely Deathblow For Its Highly Watched NASH Drug
Via Investor's Business Daily
Why These 3 Nasdaq Stocks Buckled Today
Via The Motley Fool
Analyst Expectations for Madrigal Pharmaceuticals's Future
Via Benzinga
Why Madrigal Pharmaceuticals Stock Is Slumping Today
Via The Motley Fool
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 3/17 Morning Trading
Via Investor Brand Network
Viking Therapeutics Outperforms Expectations: Analyst Increases Price Target Following Successful VK2809 Trial
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Biotechs That Might Get Bought Out in 2023
Via The Motley Fool
Why Madrigal Pharmaceuticals Stock Gained 20% This Week
Via The Motley Fool
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
Via Benzinga
Why Top 1% Biotech Madrigal Pharmaceuticals Just Surged Closer To A Breakout
Via Investor's Business Daily
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
5 Best Stocks to Buy in April
Via The Motley Fool
Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run
Via The Motley Fool
Is Viking Therapeutics a Smart Buy on the Dip?
Via The Motley Fool
Want Diversified Upside in Biotechnology? Check out LABU
Via MarketBeat
Topics ETFs Stocks
Exposures US Equities
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
Via InvestorPlace
Intercept Tumbles As Its Experimental NASH Drug Faces Yet Another Obstacle
Via Investor's Business Daily
1 Incredible Growth Stock That Could Turn $200,000 Into $1 Million by 2030
Via The Motley Fool
3 Incredible Growth Stocks to Buy if the Market Dips
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.